NEW YORK, Nov. 28 /PRNewswire/ -- Carl Marks & Co. LP has partnered with BlueStar Capital Management LP to launch the BlueStar CM Life Sciences Focus Fund LP. The partnership also gives Carl Marks a stake in BlueStar Capital Management, which invests in healthcare hedge funds, and an increased presence in the healthcare investment sector.
The new Focus Fund invests in highly concentrated portfolios which are long and short public healthcare equities, in both managed accounts and limited partnerships.
"We feel the healthcare market provides attractive and solid investment opportunities," said Mark Claster, president of Carl Marks & Co., "and BlueStar Capital Management's long experience with healthcare hedge funds makes this the perfect strategic relationship for our investment interests."
Carl Marks's Andrew Boas will join BlueStar Capital's Advisory Board. Boas is a principal of Carl Marks Management Company.
Jonathan Lach of BlueStar Capital said, "The Focus Fund is invested in the best ideas of some of the best investors in public healthcare equities, a sector that is rich with investment opportunity. We are very pleased to be partnering with Carl Marks, an extremely fine firm with much to contribute to our mutual success."
About Carl Marks & Co.
Founded in 1925, Carl Marks began as a dealer of foreign securities in the United States. The company has diversified into a multi-faceted investment and advisory services firm offering a range of specialized services, including corporate revitalization and investment banking, distressed securities, private equity, real estate and asset management. For more information, visit http://www.carlmarks.com.
About BlueStar Capital Management LP
BlueStar Capital Management LP invests primarily in healthcare hedge
funds and provides investment and consulting services for its clients in
this dynamic investment sector
|SOURCE Carl Marks & Co. LP|
Copyright©2007 PR Newswire.
All rights reserved